title: The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer--a systematic review and meta-analysis.
abstract: The sentinel lymph node biopsy (SLNB) is now an accepted alternative to the axillary lymph node dissection for pathologic evaluation of the axilla in patients with early breast cancer. The use of SLNB after neoadjuvant chemotherapy (NAC) is controversial. This meta-analysis aims to determine the feasibility and the accuracy of SLNB in the population of patients who are clinically node-negative after NAC for breast cancer.
authors: Department of General Surgery, Singapore General Hospital, Singapore, Singapore. vquetan@gmail.com
authors: Veronique K M
authors: VK
authors: Tan
authors: Brian K P
authors: BK
authors: Goh
authors: Stephanie
authors: S
authors: Fook-Chong
authors: Lay-Wai
authors: LW
authors: Khin
authors: Wai-Keong
authors: WK
authors: Wong
authors: Wei-Sean
authors: WS
authors: Yong
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D015201:Meta-Analysis as Topic; D021701:Sentinel Lymph Node Biopsy
chemical_list: D000970:Antineoplastic Agents